Form 4: Senseonics CEO Boosts Stake Post-Reverse Split

Senseonics Holdings, Inc. CEO Timothy T. Goodnow purchased 17,210 shares of common stock at a weighted average price of $5.87, increasing his direct beneficial ownership to 661,085 shares, adjusted for a recent 1-for-20 reverse stock split.

Summary

• Timothy T. Goodnow, President and CEO, and a Director of Senseonics Holdings, Inc. (SENS), acquired 17,210 shares of common stock.
• The transaction occurred on November 7, 2025, at a weighted average price of $5.87 per share, with prices ranging from $5.80 to $5.90.
• Following this purchase, Mr. Goodnow directly beneficially owns 661,085 shares of Senseonics Holdings, Inc. common stock.
• The reported share count has been adjusted to reflect a 1-for-20 reverse stock split of the Issuer's common stock, effective October 17, 2025.
• The purchase was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 7

Explanation: The CEO's insider purchase is a positive signal of confidence, especially after a reverse stock split. However, the reverse split itself indicates prior challenges, tempering the overall positive sentiment.

Positives

• The CEO's purchase of 17,210 shares signals management confidence in the company's future prospects, especially following a significant corporate action like a reverse stock split.
• The transaction was executed under a Rule 10b5-1(c) plan, indicating a pre-planned purchase strategy.

Negatives

• The recent 1-for-20 reverse stock split, effective October 17, 2025, often indicates a company's stock price has fallen significantly, potentially reflecting underlying business challenges or market skepticism.

Risks

• The reverse stock split may indicate ongoing challenges in maintaining a higher share price, which could impact investor sentiment and liquidity.
• Future stock performance remains subject to market conditions and the company's operational execution post-split.

Industry Context

Senseonics Holdings, Inc. operates in the medical technology sector, specifically focusing on continuous glucose monitoring. The recent reverse stock split suggests the company may have faced challenges in maintaining its share price, a common occurrence for smaller growth-oriented companies in the biotech and medtech industries that may need to meet exchange listing requirements or improve investor perception.

Related Party Transactions

• Timothy T. Goodnow, President and CEO, and a Director, purchased 17,210 shares of the company's common stock.

Stakeholder Impact

• Shareholders may interpret the CEO's purchase as a vote of confidence, potentially leading to increased investor interest or stabilization of the stock price.
• The context of the reverse stock split may lead some shareholders to remain cautious despite the insider buying.

Key Dates

Recommendation

The CEO's purchase of shares is a positive indicator of management confidence, particularly following a reverse stock split. While insider buying can be a bullish signal, the reverse split itself often suggests underlying challenges or a need to meet listing requirements. Therefore, a 'hold' recommendation is appropriate, acknowledging the positive insider action while recognizing the broader context that led to the reverse split and the need for further fundamental improvements.

Keywords

Senseonics Holdings, SENS, Insider Purchase, CEO Stock Buy, Timothy T. Goodnow, Reverse Stock Split, Form 4, Beneficial Ownership, Medical Technology, Continuous Glucose Monitoring